Serotyping is a useful tool to study the epidemiologic characteristics of rotaviruses in large populations and to assess the need for a vaccine to protect against all strains. By using an enzyme immunoassay with serotype-specific monoclonal antibodies to the four most common rotavirus serotypes, we analyzed 1,183 rotavirus-positive specimens from 16 stool collections in eight countries on four continents that were obtained from 1978 to 1989. Of the 926 strains (78%) that could be serotyped, 48% were serotype 1, 8% were serotype 2, 15% were serotype 3, and 7% were serotype 4. Twenty-two percent had insufficient numbers of doubleshelled virus particles to react with the monoclonal antibody of the VP4 rotavirus protein and therefore could not be serotyped. Our results indicate that vaccines being developed must provide the greatest coverage against serotype 1 and that the serotype distribution cannot be predicted currently by the geographic area or prevalence in the preceding year.
Group A rotaviruses are the most important cause of hospitalizations and deaths due to diarrhea in children under 2 years of age in both developed and developing countries (7, 9, 21, 22) . Virtually all children are infected by 5 years of age. While the detection of rotaviruses by enzyme immunoassays (EIAs) has become a simple, routine procedure, the serotyping of individual strains can provide additional insights into the epidemiologic features of rotavirus diarrhea. From recent studies of rotavirus surveillance, geographic and temporal patterns of disease in the United States and throughout the world have been identified; these might be clarified if more detailed knowledge of the distribution of the strains were available (26) . Similarly, while early vaccine trials with the bovine rotavirus vaccine (RIT 4237, serotype 6) demonstrated good heterotypic protection against rotaviruses of serotypes 1 and 2 (41) , subsequent studies with the monovalent rhesus rotavirus vaccine (serotype 3) suggested that homotypic protection was probably important as well (10) . Consequently, the distribution of serotypes in a population could alter the effectiveness of vaccines being tested.
Four major and two minor serotypes of human rotavirus have been identified on the basis of the major neutralization glycoprotein, VP7, which is present in the outer capsid of the virus. In the past, the serotyping of rotavirus has been dependent on the ability to grow different viral strains in cell culture and neutralize them with type-specific antiserum (43) . The recent development of monoclonal antibodies (MAbs) that specifically and selectively bind to the VP7 glycoprotein of each of the four most-common rotavirus serotypes (serotypes 1 to 4) has made it possible to serotype large collections of specimens by EIA (35) .
To examine the global distribution of rotavirus serotypes (1981) (1982) (1983) (1984) (1985) . Other collections came from children with diarrhea in day-care centers in Phoenix, Ariz. (1981 Ariz. ( -1983 (2) , from specimens submitted to a diagnostic laboratory that serves the southeastern United States (1987) (1988) , and from newborns with both symptomatic and asymptomatic infections in South Africa (1978) (29) . The five remaining collections from the United States were serotyped as part of an investigation to examine the distribution of rotaviruses in the United States for the period from 1987 to 1989 (19) . For 3 of the 16 collections (Costa Rica, China, and White River, Ariz.), (14) 15 (6) 28 (11) 8 (3) 13 (5) Philadelphia, Pa.
1987-1989 30
77 (23) 3 (1) 17 (5) 0 (0) 3 (1) Buffalo, N.Y. (40) 16 (26) 31 (51) 6 (11) 23 (38) Costa Rica 1983-1987 184 8 (15) 7 (12) 6 (11) 28 (52) 51 ( (5) 52 (16) 0 (0) 32 (10) China 1982-1986 80 47 (38) 29 (23) 14 (11) 0 (0) 10 (8) Korea 1988 138 52 (71) 4 (6) 1 (1) 0 (0) 43 (60) Israel 1987 97 55 (52) 10 (10) 0 (0) 19 (19) 16 (16 specimens were available for a 5-year period and were analyzed both together and for individual years to evaluate changes in the distribution of serotypes in the same area over time.
Several points should be noted about these collections: (i) the specimens were collected from several different groups of children with diarrhea including newborns, children in day-care centers, and ambulatory and hospitalized patients; (ii) some collections span a limited time period; (iii) some collections are small, such as those from South Africa and Peru; and (iv) some of the collections which span several years have limited numbers of samples. They are not meant to be representative of patterns in a specific place or (4) (14) 15 (6) 28 (11) Three of the collections represent samples obtained every year for 5 years and provide some insight into the variability of rotavirus strains in a single location over time (Table 2) . In Costa Rica, serotype 4 was the only strain identified for 2 years, after which it was displaced during the next 2 years by serotypes 2 and 3, which gave way the last year to serotype 1. A large number of these strains (51%) could not be serotyped, and this inability to serotype was not related to the age of the specimens in this collection. In Lanzhou, China, serotype 1 was the predominant serotype for 4 of the 5 years, serotype 2 was predominant for a single year, serotype 3 strains were prevalent in a third of cases for two consecutive years, and serotype 4 was absent. In Arizona, with the smallest number of strains, serotypes 1, 2, and 3 shared predominance from year to year.
Data from 28 studies of rotavirus serotypes published previously were identified in the Medline search and reviewed (Table 3) . A total of 5,419 specimens were tested, and 74% were serotyped. Serotypes were determined in 26 studies by EIAs with MAbs, in 1 study (Italy) by solid-phase immunoelectron microscopy, and in 1 study (Kenya) by neutralization. Overall, serotype 1 was the most prevalent serotype (61%), and it was the predominant serotype in 30, 1992 on July 22, 2015 by NIH Library http://jcm.asm.org/ Downloaded from a high proportion of nonserotypeable strains (i.e., samples that were VP4-positive by EIA but could not be serotyped) must be examined further for other less-common serotypes (S8, S9, and S12) or new serotypes yet to be described. While 78% of all strains could be serotyped using the four MAbs, the rates of nontypeable isolates varied greatly, from 50% in Costa Rica to none in Peru.
The serotyping technique described herein is easily reproducible and suitable to study large collections of epidemiologic interest. At the same time, it is based on MAbs binding to single VP7 epitopes. Recent studies have demonstrated that subtypes of rotavirus serotypes 1 (4) and 4 (15) exist, on the basis of the binding of their VP7 polypeptides to some neutralizing, serotype-specific MAbs but not others. These subtypes have been designated monotypes by some workers (4) . Although insufficient intact virions may account for most nontypeable strains (about 30% in most studies), data that some isolates of rotaviruses do not bind to all MAbs commonly used in serotyping have been presented (42) . Due to these epitope variations of isolates, it has been suggested that the range of this method could be enhanced by the use of MAbs specific for more than one VP7 epitope (42) . The range of the method may also be enhanced by the addition of MAbs for serotypes 8, 9, and 12, which appear to be uncommon except in certain geographic regions. Other techniques for serotyping nontypeable strains include the polymerase chain reaction (18) , nucleotide sequencing (20) , hybridization methods (11, 34) , and solid-phase immunoelectron microscopy (15) . The polymerase chain reaction is also amenable to the identification of new serotypes through the addition of new primers as sequence information becomes available.
Recent studies have delineated the human rotaviruses into three VP4 serotypes and one subtype (17) . These results suggest that a more-complete characterization of strains in the future will depend upon the neutralization associated with VP4 as well as VP7 polypeptides. Techniques already developed for VP7 serotyping may also be applicable for VP4. Neutralizing MAbs that can be used to separate human rotaviruses into four overlapping VP4-antigenic groups have already been reported (24) . Although these antibodies are not specific enough to distinguish all VP4-antigenic groups in a solid-phase assay, it is plausible that these and other antibodies may be used to develop an EIA-based serotyping method for VP4. Similarly, a hybridization-based method for the discrimination of gene 4 types has been reported (25) . When reduced to practice, these methods will allow a more complete understanding of the prevalence of rotavirus genes important for neutralization and help in the design of future vaccine candidates.
